Tenderwize
Zurück zur Suche

Open house Arzneimittelrabattverträge zum Wirkstoff Zidovudin und Lamivudin, ATC J05AR01

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 217 days left·Open·Supplies
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Zidovudin und Lamivudin, ATC J05AR01

30/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Warum diese Bewertung?

Chance

30 / 100

Komplexität

20 / 100

Risikofaktoren

The buyer reserves the right to replace open house contracts with exclusive contracts from tenders at any time, resulti...

No estimated value, minimum volume, or discount rate is disclosed. The actual business volume is uncertain.

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Supply of pharmaceutical products containing the active substances Zidovudin and Lamivudin (ATC J05AR01) for the German market.
  • Participation in a non-exclusive open house discount agreement scheme.
Vollständige Zusammenfassung anzeigen

Open house model for non-exclusive discount agreements on pharmaceuticals with active substances Zidovudin and Lamivudin (ATC J05AR01). The AOK Rheinland-Pfalz/Saarland invites all interested pharmaceutical companies to conclude uniform discount contracts without a competitive award procedure. Contracts run for a maximum of 24 months from June 2025, with rolling entry possible at the start of each month. The buyer may replace these agreements with exclusive contracts via tenders. No estimated value or award criteria are specified. This is not a public procurement under EU directive 2014/24.

Risiken

The buyer reserves the right to replace open house contracts with exclusive contracts from tenders at any time, resulti...

No estimated value, minimum volume, or discount rate is disclosed. The actual business volume is uncertain.

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Pharmaceutical products must be authorized and marketable in Germany.
  • Proof of marketability via Lauer-Taxe listing or AMIce database extract.

Administrative

  • Submission of signed contract documents before each desired start date.

Auftraggeber

Lose (1)

LOT-0001

Open house Arzneimittelrabattverträge zum Wirkstoff Zidovudin und Lamivudin, ATC J05AR01

Non-exclusive discount agreements for pharmaceuticals containing Zidovudin and Lamivudin. Uniform terms for all participants. All licensed pharmaceutical companies with marketable products in Germany can join. Contracts start at the earliest on 01.06.2025 and end at the latest on 31.05.2027. Rolling entry possible on the 1st of each month with submission by end of the month preceding the desired start month.

SuppliesEU fundedElectronic submission

Ort

Eisenberg, Germany

Dauer

May 2025 - May 2027

Kategorie

Pharmaceutical products

Frist

Deadline Mar 31, 2027

Vergabedetails

Veröffentlichungsdatum
10 Apr 2025
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
237769-2025

Dokumente (1)

Ähnliche Ausschreibungen